Prognostic Significance of Epidermal Growth Factor Receptor in Patients of Glioblastoma Multiforme
Journal Title: Journal of Clinical and Diagnostic Research - Year 2017, Vol 11, Issue 8
Abstract
Introduction: Glioblastoma Multiforme (GBM) is the most aggressive glial tumour with hallmark characteristics of rampant proliferation of glial cells along with high pleomorphism, necrosis, endothelial proliferation and high MIB-1 labeling index (cell proliferation marker). These tumours are managed by surgery followed by Radiotherapy (RT), Chemotherapy (CT) and adjuvant CT Temozolomide (TMZ). Aim: To evaluate Epidermal Growth Factor Receptor (EGFR) protein expression in GBM patients. Materials and Methods: The study comprised of 52 cases of GBM diagnosed by histomorphology from biopsy specimens. Ancillary techniques like Immunohistochemistry (IHC) for Glial Fibrillary Acidic Protein (GFAP), cell proliferation marker (MIB-1 labeling index, P53 expressions) were done in all cases. EGFR protein expression was assessed by IHC as the percentage of positive tumour cells in hot spots (10 high power fields). Response to therapy was assessed at three months post therapy by using World Health Organization (WHO) Response Evaluation Criteria In Solid Tumours (RECIST) guideline. Statistical analysis was performed by using IBM-Statistical Package for Social Sciences (SPSS) software, version 20. The p-value of ≤ 0.05 was considered significant. The mean survival of the patients was calculated using unpaired t-test and ANOVA (analysis of variance) test. Results: Out of 52 cases, thirty cases was EGFR positive and 22 cases were EGFR negative. Response to therapy was evident in 33 (63.5%) cases and 19 cases (36.5%) were non responders. The responders with EGFR negative were 86.4% and EGFR positive were 46.7% with a p-value of 0.003. The mean survival among EGFR positive and negative GBM were 315.73±257.54 and 657.91±305.88 days respectively with a significant p-value of 0.001. Conclusion: EGFR negative patients respond better to therapy along with longer duration of survival as compared to EGFR positive patient.
Authors and Affiliations
Kalpalata Tripathy, Bidyutprava Das, Ajit Kumar Singh, Aparajita Misra, Sanjib Misra, Sudhansu Sekhar Misra
Keywords
Related Articles
- EP ID EP358188
- DOI 10.7860/JCDR/2017/30138.10327
- Views 78
- Downloads 0
Dental Avengers: Taking Retainer Stability and Aesthetics into Next Era
Adult patients are realizing that practical, realistic options now exist to “straighten” their teeth because the cosmetic dentistry revolution has begun to include even “adult short-term cosmetic orthodontics” as an inte...
Difficulty in Cytological Diagnosis of Clear Cell Sarcoma - A Clinicopathological Correlation
ABSTRACT The rarity of Clear Cell Sarcoma (CCS) and its overlapping morphology with other soft tissue tumours brings diagnosis under suspicion. Several series have described histopathologic features however, only few ser...
Therapeutic Effects of Green Tea on Nonalcoholic Fatty Liver Disease in 10-16-Year-Old Children
ABSTRACT Introduction: Nonalcoholic Fatty Liver Disease (NAFLD) is characterised by fat accumulation in the liver. Treatment of NAFLD in children is an important issue but the options are limited. Green tea has antioxida...
Anatomic Landmarks to Identify the Radial Nerve during the Posterior Approach of the Humerus: A Cadaveric Study
ABSTRACT Introduction: Identification of the radial nerve and preventing injury to it is crucial, while surgically approaching the humerus from the posterior aspect to treat fractures of the midshaft or the distal third...
Oral Carcinoma Cuniculatum: A New Entity in the Clinicopathological Spectrum of Oral Squamous Cell Carcinoma
Carcinoma cuniculatum is principally recognized as a variant of carcinoma involving foot. The World Health Organization (WHO) recognizes Oral Carcinoma Cuniculatum (OCC) as a distinct and rare clinicopathological variant...